Erythropoietin receptor

Erythropoietin receptor

The erythropoietin receptor (EpoR) is a protein found on the surface of red blood cell precursors in the bone marrow. It is a member of the cytokine receptor family and plays a crucial role in the regulation of erythropoiesis, the process by which new red blood cells are produced.

Diagram of truncated erythropoietin receptors.

Structure

The erythropoietin receptor is a transmembrane protein that consists of an extracellular domain, a single transmembrane helix, and an intracellular domain. The extracellular domain is responsible for binding erythropoietin (Epo), a hormone produced primarily by the kidneys in response to low oxygen levels in the blood.

Function

Upon binding of erythropoietin to its receptor, the EpoR undergoes a conformational change that activates its intracellular signaling pathways. This activation leads to the proliferation and differentiation of erythroid progenitor cells into mature red blood cells. The primary signaling pathway involves the activation of Janus kinase 2 (JAK2) and subsequent phosphorylation of signal transducer and activator of transcription 5 (STAT5), which translocates to the nucleus to regulate gene expression.

Clinical significance

Mutations or dysregulation of the erythropoietin receptor can lead to various hematological disorders. Overexpression or constitutive activation of EpoR is associated with certain types of cancer, such as polycythemia vera, where there is an overproduction of red blood cells. Conversely, insufficient EpoR activity can result in anemia, a condition characterized by a deficiency of red blood cells.

Related pages

• Erythropoietin
• Red blood cell
• Bone marrow
• Cytokine receptor
• Janus kinase 2